Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clinical and Translational Science|July 27, 2022
Pharmacogenetics of taxane-induced neurotoxicity in breast cancer: Systematic review and meta-analysisAlberto Guijosa, Ana Freyria, Jose Rodrigo Espinosa-Fernandez, et al.
Journal of Oncology|December 5, 2022
The Prognostic Significance of HALP Index for Colon Cancer Patients in a Hispanic-Based PopulationGerman Calderillo Ruiz, Horacio Lopez Basave, Rafael Sebastian Vazquez Renteria, et al.
Mini Reviews in Medicinal Chemistry|February 22, 2023
Examining the Role of Histaminergic, Orexinergic, and Cannabinergic Systems in Redox Regulation in Gastric AdenocarcinomaAna Laura Torres-Román, Karla Lucero Rodríguez-Flores, Víctor Manuel Hernández-Mora, et al.
Clinical Lung Cancer|February 4, 2025
Elucidating the Role of EGFRL858R in Brain Metastasis Among Patients With Advanced NSCLC Undergoing TKI TherapyEduardo Rios-Garcia, Alberto Guijosa, Enrique Caballé-Perez, et al.
Frontiers in Oncology|February 18, 2025
Case report: Chest radiotherapy-induced vertebral fractures in lung cancer patients: a case series and literature reviewOscar Arrieta, Francisco Lozano-Ruiz, Alberto Guijosa, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
Correction: Alvarado-Miranda et al. Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer. Curr. Oncol. 2023, 30, 6097-6110Alberto Alvarado-Miranda, Fernando Ulises Lara-Medina, Wendy R Muñoz-Montaño, et al.
Journal of Medicinal Chemistry|January 3, 2026
Discovery and Characterization of a First-In-Class HCK/BTK PROTAC DFCI-002-06 for the Treatment of MYD88 Mutated B Cell MalignanciesJohn M Hatcher, Shirong Liu, Amanda Kofides, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast CancerAlberto Alvarado-Miranda, Fernando Ulises Lara-Medina, Wendy R Muñoz-Montaño, et al.
Blood Advances|July 17, 2025
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemiaJorge J Castillo, Alberto Guijosa, John N Allan, et al.
BMC Infectious Diseases|February 24, 2025
Validation and implementation of TaqMAMA RT-PCR for SARS-CoV-2 variant surveillance: experience from a high-volume settingJosé Nicolas Aguirre-Pineda, Mario Alberto Mújica-Sánchez, Hansel Hugo Chávez-Morales, et al.
Pageof 3